Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0BWCTV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ARX-305
|
|||||
| Synonyms |
ARX 305; ARX-305; ARX305; NCB-002
Click to Show/Hide
|
|||||
| Organization |
Ambrx, Inc.; Zhejiang Medicine Co., Ltd.; Novocodex Biopharmaceuticals Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 3 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
A proprietary, humanized, anti-CD70 antibody
|
Antibody Info | ||||
| Antigen Name |
CD70 antigen (CD70)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin F
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Oxime-PEG3
|
Linker Info | ||||
| Conjugate Type |
Non-natural Amino Acids
|
|||||
| Combination Type |
amberstatin
|
|||||
